|
Feb 10
|
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2024 Financial Results
|
|
Feb 4
|
Estimating The Fair Value Of Artivion, Inc. (NYSE:AORT)
|
|
Dec 9
|
Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis
|